Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: A review of the literature

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 3, 2011, Pages 267-274

  Tufano, Antonella ^a   Guida, Anna ^a   Dario Di Minno, Matteo Nicola ^a   Prisco, Domenico ^b   Cerbone, Anna Maria ^a   Di Minno, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

antiplatelet agents; medical patients; primary prophylaxis; thrombocytopenia; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENESIS INHIBITOR; CLOPIDOGREL; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NEUROLEPTIC AGENT; THROMBOPOIETIN; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ACUTE RESPIRATORY FAILURE; AGING; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOVASCULAR RISK; CENTRAL VENOUS CATHETER; CHRONIC ANTIPLATELET TREATMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COCHRANE LIBRARY; COMPRESSION GARMENT; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DEATH; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; ENTERITIS; FAMILY HISTORY; HEART FAILURE; HEPATITIS C; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; IMMOBILIZATION; INCIDENCE; INFORMATION RETRIEVAL; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; ISCHEMIC HEART DISEASE; LIVER CIRRHOSIS; LIVER FIBROSIS; LUNG EMBOLISM; MEDLINE; MYELOPROLIFERATIVE DISORDER; NEOPLASM; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; OBESITY; ORAL CONTRACEPTION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; PUERPERIUM; RECURRENT DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEPSIS; SPONTANEOUS ABORTION; SUPERFICIAL VEIN THROMBOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT WITHDRAWAL; VARICOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; HUMANS; LIVER CIRRHOSIS; RISK FACTORS; THROMBOCYTOPENIA; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

EID: 79953654316     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1273090     Document Type: Article

References (51)

1. Anderson F A. Jr, Wheeler H B., Goldberg R J. et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991 151 5 933-938
2. Rubinstein I, Murray D, Hoffstein V. Fatal pulmonary emboli in hospitalized patients. An autopsy study. Arch Intern Med 1988 148 6 1425-1426
3. Di Minno G, Mannucci P M., Tufano A et al, First Ambulatory Screening On Thromboembolism (fast) Study Group. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J Thromb Haemost 2005 3 7 1459-1466 (Pubitemid 41725204)
4. Samama M M., Cohen A T., Darmon J-Y et al. A comparison of enoxaparin with placebo for the prevention of VTE in acutely ill medical patients. Prophylaxis in Medical Patients Study Group. N Engl J Med 1999 341 11 793-800 (Pubitemid 29420474)
5. Leizorovicz A, Cohen A T., Turpie A G., Olsson C G., Vaitkus P T., Goldhaber S Z., PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004 110 7 874-879 (Pubitemid 39096017)
6. Cohen A T., Davidson B L., Gallus A S. et al, ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006 332 7537 325-329
7. Geerts W H., Bergkvist D, Pineo G F. et al. Prevention of venous thromboembolism: ACCP Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 6, Suppl 381S-453S (Pubitemid 351894916)
8. Tapson V F., Decousus H, Pini M et al, IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007 132 3 936-945
9. Monreal M, Kakkar A K., Caprini J A. et al, RIETE Investigators. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004 2 11 1892-1898 (Pubitemid 40192740)
10. Cohen A T., Tapson V F., Bergmann J F. et al, ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008 371 9610 387-394 (Pubitemid 351173321)
11. Lippi G, Favaloro E J., Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin Thromb Hemost 2011 37 3 237-251
12. Prandoni P, Samama M M. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients. Br J Haematol 2008 141 5 587-597 (Pubitemid 351667624)
13. Maynard G A., Morris T A., Jenkins I H. et al. Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med 2010 5 1 10-18
14. Senzolo M, Sartori M T., Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford) 2009 11 6 459-464
15. Northup P G., Caldwell S H. New concepts of coagulation and bleeding in liver disease. Intern Emerg Med 2010 5 1 3-6
16. Tripodi A, Primignani M, Mannucci P M. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med 2010 5 1 7-12
17. Northup P G., McMahon M M., Ruhl A P. et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006 101 7 1524-1528 quiz 1680 (Pubitemid 43980626)
18. Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost 1979 42 2 564-570 (Pubitemid 10229868)
19. Wanless I R., Wong F, Blendis L M., Greig P, Heathcote E J., Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995 21 5 1238-1247
20. Amitrano L, Guardascione M A., Ames P R. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clin Lab 2007 53 9-12 583-589 (Pubitemid 351166424)
21. Søgaard K K., Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen H T. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009 104 1 96-101
22. Tripodi A, Primignani M, Chantarangkul V et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009 137 6 2105-2111
23. Kaushansky K. Thrombopoietin. N Engl J Med 1998 339 11 746-754 (Pubitemid 28417359)
24. Adinolfi L E., Giordano M G., Andreana A et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 2001 113 3 590-595 (Pubitemid 32524375)
25. Giannini E, Borro P, Botta F et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol 2002 37 5 572-577 (Pubitemid 35305535)
26. Wang C S., Yao W J., Wang S T., Chang T T., Chou P. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection. Clin Infect Dis 2004 39 6 790-796 (Pubitemid 39244291)
27. Lisman T, Bongers T N., Adelmeijer J et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006 44 1 53-61 (Pubitemid 44049138)
28. Afdhal N, McHutchison J, Brown R et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008 48 6 1000-1007
29. Amitrano L, Guardascione M A., Menchise A et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010 44 6 448-451
30. Lyman G H., Khorana A A., Falanga A et al, American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007 25 34 5490-5505 (Pubitemid 350232226)
31. Tosetto A, Balduini C L., Cattaneo M et al, Italian Society for Haemostasis and Thrombosis. Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009 124 5 e13-e18
32. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol 2005 6 6 401-410 (Pubitemid 40753746)
33. Caine G J., Stonelake P S., Lip G YH, Kehoe S T. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002 4 6 465-473 (Pubitemid 35417069)
34. Lee A Y., Levine M N. Venous thromboembolism and cancer: risks and outcomes. Circulation 2003 107 23, Suppl 1 I17-I21 (Pubitemid 41289267)
35. Caine G J., Stonelake P S., Rea D, Lip G YH. Coagulopathic complications in breast cancer. Cancer 2003 98 8 1578-1586 (Pubitemid 37238612)
36. Heit J A., Silverstein M D., Mohr D N., Petterson T M., O'Fallon W M., Melton L J. III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000 160 6 809-815 (Pubitemid 30165241)
37. Falanga A, Donati M B. Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 2001 73 2 137-144 (Pubitemid 33758852)
38. Rickles F R., Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001 102 6 V215-V224 (Pubitemid 32539212)
39. Baron J A., Gridley G, Weiderpass E, Nyrén O, Linet M. Venous thromboembolism and cancer. Lancet 1998 351 9109 1077-1080 (Pubitemid 28163410)
40. Rickles F R., Falanga A, Montesinos P, Sanz M A., Brenner B, Barbui T. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? Thromb Res 2007 120 Suppl 2 S99-S106 (Pubitemid 350110475)
41. Herishanu Y, Misgav M, Kirgner I, Ben-Tal O, Eldor A, Naparstek E. Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens. Leuk Lymphoma 2004 45 7 1407-1411 (Pubitemid 38701918)
42. Cortelezzi A, Moia M, Falanga A et al, CATHEM Study Group. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol 2005 129 6 811-817 (Pubitemid 40904533)
43. Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009 233-239
44. Metjian A, Lim W. ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis? Hematology Am Soc Hematol Educ Program 2009 247-249
45. Kitchens C S. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematology Am Soc Hematol Educ Program 2009 240-246
46. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 7329 71-86
47. Douketis J D., Berger P B., Dunn A S. et al, American College of Chest Physicians. The perioperative management of antithrombotic therapy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 6, Suppl 299S-339S (Pubitemid 351894915)
48. Biondi-Zoccai G GL, Lotrionte M, Agostoni P et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006 27 22 2667-2674 (Pubitemid 44729867)
49. Di Minno M ND, Prisco D, Ruocco A L., Mastronardi P, Massa S, Di Minno G. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med 2009 4 4 279-288
50. Kamphuisen P W., Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res 2007 119 3 265-274 (Pubitemid 44920433)
51. Chassot P G., Delabays A, Spahn D R. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007 99 3 316-328 (Pubitemid 47321534)